Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk

Area of Science:

• Genetics
• Pediatric Oncology
• Developmental Biology

Background:

• Children with congenital heart disease (CHD) exhibit a higher risk of developing neuroblastoma (NB).
• This increased risk may stem from shared developmental origins, particularly involving neural crest cells.

Purpose of the Study:

• To investigate rare exonic de novo single-nucleotide variants (SNVs) in children with CHD and NB.
• To identify shared genetic factors that may contribute to the co-occurrence of these conditions.

Main Methods:

• Analysis of rare exonic de novo SNVs in 702 CHD trios and 454 NB trios.
• Data sourced from the Neuroblastoma Epidemiology in North America Study, Gabriella Miller Kids First Program, and a published cohort.

Main Results:

• Seven genes, including known CHD risk genes POGZ and LZTR1, showed nominal enrichment (p < 0.05) in both CHD and NB cohorts.
• Genes such as CIC, IREB2, POGZ, and PCDHG cluster, associated with neurodevelopmental disorders, were implicated.
• These findings suggest shared genetic underpinnings and developmental mechanisms.

Conclusions:

• Shared genetic pathways may link congenital anomalies like CHD with childhood cancers such as NB.
• Further research into these pathways is warranted to understand the etiology of both conditions.